# FDA Inspection 1260116 - AMPI - January 31, 2025

Source: https://www.keypedia.com/records/fda_inspections/ampi/9e5404d0-b48a-4aa1-a9bd-432367b38610
Source feed: FDA_Inspections

> FDA inspection 1260116 of AMPI, January 31, 2025. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260116
- Company Name: AMPI
- Inspection Date: 2025-01-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1279127 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/ampi/f13096bc-a092-42c5-b223-c8c5a4df203c)
- FDA Inspection 1149078 - 2021-08-11
- [FDA Inspection 1030953 - 2017-11-03](https://www.keypedia.com/records/fda_inspections/ampi/1894c052-4e26-4f81-841e-54a55faeac3f)
- FDA Inspection 936865 - 2015-07-21
- FDA Inspection 783193 - 2012-05-03

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/christopher-m-jeffers/327faaff-619a-4180-ab4c-b5f1b5ba84be)

Company: https://www.keypedia.com/companies/ampi/068c0462-6f2a-4e3a-b16f-9160266df114

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c